Larvol Delta - Safety-Tolerability-and-Preliminary-Efficacy-of-Soquelitinib-in-Participants-With-Moderate-to-Severe-AD

soquelitinib (CPI-818) - Corvus Pharma

http://clinicaltrials.gov/ct2/show/NCT06345404

Mar 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next